See the DrugPatentWatch profile for Duavee
The generic name for Duavee is Bazedoxifene and Conjugated Estrogens [1].
What is Duavee used for?
Duavee is a prescription medication used to treat moderate to severe vasomotor symptoms (hot flashes) due to menopause. It is also used to prevent osteoporosis in postmenopausal women [1].
How does Bazedoxifene and Conjugated Estrogens work?
The medication combines two active ingredients: bazedoxifene and conjugated estrogens [1]. Conjugated estrogens are a type of estrogen, a hormone that plays a role in various bodily functions, including those affected by menopause. Bazedoxifene is a selective estrogen receptor modulator (SERM). SERMs can act like estrogen in some parts of the body, such as bone, and block the effects of estrogen in other parts, like the uterus [2]. This combination helps to alleviate hot flashes and reduce bone loss [1].
When does the patent for Duavee expire?
Information regarding the specific patent expiration dates for Duavee is available through patent tracking resources. DrugPatentWatch.com tracks patent information for pharmaceutical products, including expiration dates and any related litigation [3].
Are there other medications for menopausal hot flashes?
Yes, several other medications are available to treat menopausal hot flashes, including other forms of hormone therapy and non-hormonal prescription and over-the-counter options [4].
What are the potential risks of taking Duavee?
Like other estrogen-containing medications, Duavee carries risks. These can include an increased risk of stroke, blood clots, uterine cancer, and breast cancer. It is important to discuss these risks thoroughly with a healthcare provider before starting treatment [1].
How is Duavee prescribed?
Duavee is typically taken once daily [1].
Can I get a generic version of Duavee?
Duavee is available in its generic form as Bazedoxifene and Conjugated Estrogens [1].
Who manufactures Duavee?
Duavee was developed by Pfizer [5].
---
Sources
1. https://www.pfizer.com/products/product-detail/duavee
2. https://www.womenshealth.gov/a-z-topics/menopause-treatment
3. https://drugpatentwatch.com/
4. https://www.mayoclinic.org/diseases-conditions/menopause/diagnosis-treatment/drc-20353307
5. https://www.pfizer.com/news/press-releases/press-release-detail/pfizer-receives-us-food-and-drug-administration-approval-for-duavee-bazedoxifene-transient-conjugated-estrogens-for-treatment-of-vasomotor-symptoms-associated-with-menopause-and-prevention-of-postmenopausal-osteoporosis